Article

IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis

Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Sendai, Japan.
The Journal of Immunology (Impact Factor: 5.36). 12/2005; 175(9):6177-89. DOI: 10.4049/jimmunol.175.9.6177
Source: PubMed

ABSTRACT In this study, we examined the biological action of IL-17 on human non-small cell lung cancer (NSCLC). Although IL-17 had no direct effect on the in vitro growth rate of NSCLC, IL-17 selectively augmented the secretion of an array of angiogenic CXC chemokines, including CXCL1, CXCL5, CXCL6, and CXCL8 but not angiostatic chemokines, by three different NSCLC lines. Endothelial cell chemotactic activity (as a measure of net angiogenic potential) was increased in response to conditioned medium from NSCLC stimulated with IL-17 compared with those from unstimulated NSCLC. Enhanced chemotactic activity was suppressed by neutralizing mAb(s) to CXCL1, CXCL5, and CXCL8 or to CXCR-2 but not to vascular endothelial growth factor-A. Transfection with IL-17 into NSCLC had no effect on the in vitro growth, whereas IL-17 transfectants grew more rapidly compared with controls when transplanted in SCID mice. This IL-17-elicited enhancement of NSCLC growth was associated with increased tumor vascularity. Moreover, treatment with anti-mouse CXCR-2-neutralizing Ab significantly attenuated the growth of both neomycin phosphotransferase gene-transfected and IL-17-transfected NSCLC tumors in SCID mice. A potential role for IL-17 in modulation of the human NSCLC phenotype was supported by the findings that, in primary NSCLC tissues, IL-17 expression was frequently detected in accumulating and infiltrating inflammatory cells and that high levels of IL-17 expression were associated with increased tumor vascularity. These results demonstrate that IL-17 increases the net angiogenic activity and in vivo growth of NSCLC via promoting CXCR-2-dependent angiogenesis and suggest that targeting CXCR-2 signaling may be a novel promising strategy to treat patients with NSCLC.

Download full-text

Full-text

Available from: Muneo Numasaki, Jul 05, 2015
0 Followers
 · 
238 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to elucidate how different oxygen levels impact the effects of Interleukin-17 (IL-17) on angiogenic properties of endothelial cells. Two endothelial cell lines, mouse MS-1 and human EA.hy 926, were grown at 20% and 3% O2 and, after IL-17 treatment, their angiogenic abilities: proliferation, apoptosis, migration and tubulogenesis were analyzed. Additionally, the expression of endothelial nitric oxide synthase (eNOS) and cyclooxygenase-2 (Cox-2) were evaluated. Considering EA.hy 926 cell line, hypoxa alone reduced the proliferation, survival and migration, while not affecting their ability to form tubules. When cultured at 20% O2 , IL-17 stimulated proliferation, migration and tubulogenesis of EA.hy 926, while in hypoxic environment did not affect their migration and proliferation, but increased their survival and tubulogenic properties. The expression of eNOS and Cox-2 in EA.hy 926 cells was increased by both IL-17 and hypoxia, as well as by their combination. Results regarding MS-1 cell line demonstrated that hypoxia did not affect proliferation, survival, migration and tubule formation of these cells. At 20% O2 , IL-17 did not alter their proliferation, inhibited migration and stimulated tubule formation. At 3% O2 , only the stimulating effect of IL-17 on tubulogenesis was evident. The constitutive expression of eNOS was not affected by oxygen concentrations nor the IL-17 supplementation, while Cox-2 expression was upregulated by both IL-17 and hypoxia. Obtained data demonstrated that the effects of IL-17 on the angiogenic properties of endothelial cells are dependent on both the cell line used and the oxygen concentration used for cultures.
    Cell Biology International 07/2013; DOI:10.1002/cbin.10144 · 1.64 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The importance of CD4 T cells in orchestrating the immune system and their role in inducing effective T cell-mediated therapies for the treatment of patients with select established malignancies are undisputable. Through a complex and balanced array of direct and indirect mechanisms of cellular activation and regulation, this functionally diverse family of lymphocytes can potentially promote tumor eradication, long-term tumor immunity, and aid in establishing and/or rebalancing immune cell homeostasis through interaction with other immune cell populations within the highly dynamic tumor environment. However, recent studies have uncovered additional functions and roles for CD4 T cells, some of which are independent of other lymphocytes, that can not only influence and contribute to tumor immunity but paradoxically promote tumor growth and progression. Here, we review the recent advances in our understanding of the various CD4 T cell lineages and their signature cytokines in disease progression and/or regression. We discuss their direct and indirect mechanistic interplay among themselves and with other responding cells of the antitumor response, their potential roles and abilities for "plasticity" and memory cell generation within the hostile tumor environment, and their potentials in cancer treatment and immunotherapy.
    Frontiers in Oncology 03/2013; 3:63. DOI:10.3389/fonc.2013.00063
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Interleukin-17 (IL-17) is a proinflammatory cytokine that is associated with inflammation, autoimmune disorders, and even tumors. Previous studies revealed that a large group of human malignant tumors have abnormally high IL-17 expression. In the present study, we analyzed two single-nucleotide polymorphisms (SNPs) in the IL17A (rs2275913) and IL17F (rs763780) in 311 cervical cancer patients and 463 controls using TaqMan assays. Our results indicated that the frequencies of AA genotype and A allele of rs2275913 were significantly different between the cervical cancer patients and controls (P = 0.008, OR = 1.32, 95% CI, 1.07-1.62). Stratified analyses revealed that the polymorphism of rs2275913 was also associated with positive peritumor intravascular cancer emboli and high clinical stage. The genotype and allele frequencies of rs763780 did not show any difference between patients and controls or relate to patient clinical characteristics. Collectively, these findings suggested that IL17 gene polymorphism rs2275913 was associated with the susceptibility as well as positive peritumor intravascular cancer emboli and high clinical stage of cervical cancer in Chinese women.
    Clinical and Developmental Immunology 01/2012; 2012:258293. DOI:10.1155/2012/258293 · 2.93 Impact Factor